Pyrrolopyrimidines as protein kinase inhibitors
Details for Australian Patent Application No. 2002314325 (hide)
International Classifications
Event Publications
2 January 2003 Complete Application Filed
Priority application(s): 0115393.1 23.06.01 GB; 60/301,678 28.06.01 US
19 June 2003 Application Open to Public Inspection
Published as AU-B-2002314325
8 January 2009 Application Accepted
Published as AU-B-2002314325
29 January 2009 Corrigenda
Applications Accepted - Name Index Under the name Aventis Pharmaceuticals Inc, Application No. 2002314325, under INID(72), correct the co-inventor name to Amendola, Shelley
7 May 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser